| Literature DB >> 29862276 |
Rauf Melekoglu1, Osman Ciftci2, Sevil Eraslan3, Saadet Alan4, Nese Basak5.
Abstract
OBJECTIVE: To evaluate the protective effects of glycyrrhetinic acid (GA) and chrysin (CH) on experimental ischemia-reperfusion (I/R) injury in rat ovaries using tissue oxidative stress marker levels, hormone levels, and histopathological scores.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29862276 PMCID: PMC5976983 DOI: 10.1155/2018/5421308
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Levels of oxidant and antioxidant parameters in rat ovarian tissues among the treatment groups.
| Group | MDA (nmol/g tissue) | GSH (nmol/mL tissue) | SOD (U/mg protein) | GPx (U/mg protein) | CAT (kU/mg protein) |
|---|---|---|---|---|---|
| Control | 6.38 ± 1.12a | 55.4 ± 2.66f | 80.1 ± 10.2k | 596.4 ± 45.9p | 0.014 ± 0.001v |
| I/R | 9.16 ± 0.98 | 35.5 ± 2.87 | 57.6 ± 14.7 | 468.9 ± 92.6 | 0.005 ± 0.001 |
| I/R + CH | 5.02 ± 1.05b | 45.2 ± 3.56g | 75.1 ± 15.1l | 595.0 ± 67.9r | 0.010 ± 0.004x |
| I/R + GA | 5.14 ± 1.23c | 50.9 ± 3.44h | 78.3 ± 12.6m | 608.8 ± 52.3s | 0.011 ± 0.005y |
| CH | 5.94 ± 1.09d | 59.5 ± 3.82i | 83.1 ± 11.5n | 612.4 ± 79.1t | 0.011 ± 0.001w |
| GA | 6.23 ± 1.34e | 54.7 ± 4.12j | 89.9 ± 18.3o | 626.3 ± 88.4u | 0.012 ± 0.002z |
a P < 0.001, P < 0.001, cP = 0.002, fP = 0.005, gP = 0.003, hP < 0.001, kP < 0.001, lP < 0.001, mP < 0.001, pP = 0.008, rP = 0.008, sP = 0.007, vP = 0.003, xP < 0.001, yP < 0.001 compared with I/R group; dP = 0.019, eP = 0.071, iP = 0.007, jP = 0.089, nP = 0.045, oP = 0.008, tP = 0.037, uP = 0.006, wP = 0.065, zP = 0.068 compared with control group; MDA, malonaldehyde; GSH, glutathione; SOD, superoxide dismutase; GPx, glutathione peroxidase; CAT, catalase; I/R, ischemia–reperfusion; CH, chrysin; GA, glycyrrhetinic acid.
Histopathological scores among treatment groups.
| Histopathological score (mean ± SD) | Hemorrhage | Edema | Vascular congestion | PMNL | Vascular proliferation | Apoptosis |
|---|---|---|---|---|---|---|
| Control | 0 ± 0a | 0.5 ± 0.1f | 0.75 ± 0.1k | 0.75 ± 0p | 1 ± 0.5u | 0.25 ± 0.1 |
| I/R | 2.5 ± 0.5 | 3 ± 0 | 3 ± 0 | 3 ± 0 | 3 ± 0 | 1 ± 0.5 |
| I/R + CH | 0 ± 0b | 1 ± 0g | 1.25 ± 0.5l | 0.25 ± 0.1q | 0.5 ± 0v | 0.5 ± 0.5 |
| I/R + GA | 0 ± 0c | 1 ± 0h | 1.25 ± 0.5m | 0 ± 0r | 1 ± 0.2x | 0.75 ± 0.5 |
| CH | 0 ± 0.1d | 0.5 ± 0.2i | 1 ± 0n | 1 ± 0s | 1.25 ± 0.25y | 0.75 ± 0.2 |
| GA | 0 ± 0e | 0.75 ± 0.1j | 1.25 ± 0o | 1.75 ± 0.5t | 2 ± 0z | 0.25 ± 0.2 |
a P = 0.001, bP < 0.001, cP < 0.001, fP < 0.001, gP < 0.001, hP < 0.001, kP < 0.001, lP = 0.001, mP = 0.001, pP < 0.001, qP < 0.001, rP < 0.001, uP < 0.001, vP < 0.001, xP < 0.001, P = 0.003, P = 0.008, P = 0.007 compared with I/R group, dP = 0.748, eP = 1.000, iP = 0.950, jP = 0.089, nP = 0.645, oP = 0.037, sP = 0.527, tP = 0.009, yP = 0.665, zP = 0.009, P = 0.003, P = 0.954 compared with the control group; I/R, ischemia-reperfusion; CH, chrysin; GA, glycyrrhetinic acid; PMNL, polymorphonuclear leukocytes.
Figure 1(a1, a2): ischemia-reperfusion (I/R) group. (a1) Vascular congestion indicated by ↑ symbol. (a2) Hemorrhage indicated by ↑ symbol ((a1): hematoxylin and eosin (H&E), 100x, scale bar = 100 μm; (a2): H&E, 40x, scale bar = 400 μm) (b1), (b2): I/R + chrysin (CH) group. Decreased vascular proliferation indicated by ↑ symbol ((b1): HE, 100x, scale bar = 200 μm; (b2): HE, 200x, scale bar = 100 μm). (c1), (c2): I/R + glycyrrhetinic acid (GA) group. Reduced PMNL infiltration is indicated by ↑ symbol, and I/R-induced apoptosis is indicated by ▯ symbol. ((c1): HE, 100x, scale bar = 100 μm; (c2): HE, 400x, scale bar = 25 μm).
Serum hormone levels among the treatment groups.
| Group | E2 (pg/mL) | FSH (IU/L) | LH (IU/L) | AMH (ng/mL) |
|---|---|---|---|---|
| Control | 73.5 ± 5.56a | 2.22 ± 0.31f | 3.24 ± 0.13k | 7.54 ± 0.77p |
| I/R | 33.2 ± 3.61 | 5.25 ± 1.00 | 4.76 ± 0.18 | 3.47 ± 0.54 |
| I/R + CH | 66.7 ± 5.25b | 3.94 ± 0.48g | 3.13 ± 0.36l | 5.36 ± 0.31r |
| I/R + GA | 62.9 ± 3.79c | 3.98 ± 0.28h | 3.10 ± 0.11m | 5.85 ± 0.60s |
| CH | 74.5 ± 6.69d | 3.29 ± 0.44i | 3.11 ± 0.11n | 7.81 ± 0.74t |
| GA | 71.3 ± 6.18e | 2.71 ± 0.28j | 3.24 ± 0.04o | 7.81 ± 0.32u |
a P < 0.001, bP < 0.001, cP < 0.001, fP < 0.001, gP = 0.002, hP = 0.001, kP = 0.004, lP = 0.003, mP = 0.003, pP < 0.001, rP = 0.007, sP = 0.005 compared with the I/R group, dP = 0.848, eP = 0.570, iP = 0.042, jP = 0.095, nP = 0.754, oP = 0.954, tP = 0.043, uP = 0.043 compared with the control group; I/R: ischemia-reperfusion; CH: chrysin; GA: glycyrrhetinic acid; E2: estradiol, FSH: follicle-stimulating hormone; LH: luteinizing hormone; AMH: anti-Müllerian hormone.